Streetbeat News

YOLO

AdvisorShares Pure Cannabis ETF

http://www.advisorshares.com/fund/yolo

Industry

Asset Management

The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business and in derivatives or other instruments that have economic characteristics similar to such securities. It is non-diversified.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Cannabis stocks surged following the start of recreational cannabis sales in Ohio and strong earnings reports from key industry players. The AdvisorShares Pure Cannabis ETF (NYSE:YOLO) rose by 8%, while Green Thumb Industries (OTC:GTBIF) and Trulieve Cannabis (OTC:TCNNF) saw significant gains. Other multi-state operators like Verano Holdings (OTC:VRNOF), Curaleaf Holdings (OTC:CURLF), Cresco Labs (OTC:CRLBF), and Ascend Wellness Holdings (OTC:AAWH) are also set to benefit from Ohio's new regulatory environment.

Portfolio Pulse from Patricio Liddle

August 06, 2024 | 10:49 pm

The DEA's call for public input on cannabis rescheduling received over 42,000 comments, with the majority supporting either rescheduling or full descheduling of cannabis. This significant public engagement highlights the importance of the issue. The potential rescheduling could benefit cannabis businesses by providing tax relief and adding jobs. The response of cannabis stocks, particularly ETFs like MSOS and YOLO, will be closely monitored.

Portfolio Pulse from Nina Zdinjak

July 24, 2024 | 1:34 pm

Cannabis stocks and ETFs saw significant movement following President Joe Biden's announcement that he will not seek re-election. Key stocks like Aurora Cannabis, Village Farms International, Tilray Brands, and SNDL experienced notable gains. Multi-state operators and cannabis ETFs also saw positive performance.

Portfolio Pulse from Nicolás Jose Rodriguez

July 22, 2024 | 10:12 pm

Cannabis stocks experienced significant volatility following President Joe Biden's announcement that he will not seek re-election. Some stocks surged while others plummeted, reflecting investor sentiment and market speculation about future regulatory changes. Cannabis ETFs also showed mixed performance, indicating cautious optimism among investors.

Portfolio Pulse from Nicolás Jose Rodriguez

July 22, 2024 | 6:12 pm

AdvisorShares Pure Cannabis ETF (NYSE:YOLO) has declared a quarterly dividend of $0.0178 per share, payable on June 28 to shareholders of record as of June 24. The ex-dividend date is also June 24. This move reflects the ongoing investor interest and resilience in the cannabis sector despite market fluctuations.

Portfolio Pulse from Javier Hasse

June 25, 2024 | 7:03 pm

The Department of Justice's move to reclassify cannabis from Schedule I to Schedule III has led to a surge in cannabis stocks and ETFs. The AdvisorShares Pure US Cannabis ETF (MSOS) and AdvisorShares Pure Cannabis ETF (YOLO) saw significant gains. Cresco Labs (CRLBF) and Gold Flora (GRAM, GRAMW) reported mixed earnings, while Trulieve Cannabis (TCNNF) led in revenue and EBITDA growth. The reclassification aligns with a Democratic strategy to advance cannabis reform ahead of elections.

Portfolio Pulse from Patricio Liddle

May 21, 2024 | 5:45 pm

President Joe Biden announced a significant move to reschedule marijuana from a Schedule I to a Schedule III drug under federal law. This decision is expected to have a positive impact on cannabis-related stocks, as evidenced by the immediate rise in their prices following the announcement.

Portfolio Pulse from Maureen Meehan

May 16, 2024 | 6:02 pm

Cannabis stocks fell after reports emerged that the DEA Administrator Anne Milgram did not sign the order to reclassify cannabis as a Schedule III drug, contrary to expectations. This decision has halted the momentum of the Biden Administration's plan to acknowledge cannabis's medical benefits and its lower potential for abuse compared to Schedule I substances.

Portfolio Pulse from Adam Eckert

May 06, 2024 | 9:09 pm

Cannabis stocks and ETFs experienced significant gains following the DEA's decision to consider rescheduling marijuana from Schedule I to Schedule III, indicating a potential shift in regulatory stance and acknowledging its medical use. This move has sparked optimism among investors about the future of the cannabis industry.

Portfolio Pulse from Jelena Martinovic

April 30, 2024 | 6:43 pm

Wana Brands' CMO, Joe Hodas, announced at Benzinga's Cannabis Capital Conference that the company is set to expand its market presence by launching in several new markets and increasing its footprint by more than 25%. Additionally, Wana Brands plans to announce new partnerships.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:12 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.